Dr. Ahmed Zayed Obeidat, MD, PhD

Dr. Obeidat practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Obeidat's NPI, 1184069627, was assigned on May 9, 2013. Dr. Obeidat holds Wisconsin license 69028.

Dr. Obeidat's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Obeidat's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Dr. Obeidat is also affiliated with Froedtert Menomonee Falls Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Obeidat to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Obeidat practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Obeidat's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Obeidat is licensed in Wisconsin.

CMS data shows 190 Medicare services from Dr. Obeidat across 4 procedure codes in 2024, for 95 Medicare patients. Medicare paid $10,122 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Dr. Obeidat in 2024. The largest group is 65 to 74, with 45 patients. 51% of them have high blood pressure, and 51% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Obeidat's median patient age at 50, with 73% women.

In 2024, Dr. Obeidat wrote 939 Medicare Part D claims for 137 patients. 80% of them were for generic drugs. CMS names the drug for 740 of them, across 24 drugs with 11 or more claims each, at $2,383,006 in total drug cost. In 2023, CMS named 543 claims across 21 drugs.

Dr. Obeidat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Obeidat as offering telehealth.

Dmand AI links 39 papers to Dr. Obeidat, published from 2014 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Multiple Sclerosis, Magnetic Resonance Imaging and Autoantibodies. Dr. Obeidat has published most often in Mult Scler Relat Disord. Dr. Obeidat's most frequent co-authors are Sam Ishmael Hooshmand, Le Hanh Hua, MD and Allison Noel Block, DO.

Dmand AI links Dr. Obeidat to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis. Open Payments lists research payments to Dr. Obeidat that name 1 trial.

CMS Open Payments shows 1,529 general payments to Dr. Obeidat from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. EMD Serono, Inc. paid the most, $440,618. It also lists 29 research payments totaling $20,792 from 2019 to 2025, naming 1 clinical trial.